{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T19:56:05Z","timestamp":1702670165053},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s00393-013-1281-z","type":"journal-article","created":{"date-parts":[[2013,12,2]],"date-time":"2013-12-02T09:03:43Z","timestamp":1385975023000},"page":"977-985","source":"Crossref","is-referenced-by-count":5,"title":["Infektinduzierte reaktive Arthritiden"],"prefix":"10.1007","volume":"72","author":[{"given":"M.","family":"Brzank","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Wollenhaupt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,12,4]]},"reference":[{"key":"1281_CR1","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s00393-010-0676-3","volume":"66","author":"Rihl","year":"2010","unstructured":"Rihl M, Kuipers JG (2010) Reaktive Arthritis \u2013 Von der Pathogenese zu neuen Therapiekonzepten. Z Rheumatol 66:864\u2013870","journal-title":"Z Rheumatol"},{"key":"1281_CR2","first-page":"211","volume":"63","author":"Haibel","year":"2004","unstructured":"Haibel H et al (2004) Diagnostik der reaktiven Arthritis. Z Rheumatol 63:211\u2013215","journal-title":"Z Rheumatol"},{"key":"1281_CR3","first-page":"453","volume":"13","author":"Wollenhaupt","year":"1995","unstructured":"Wollenhaupt J, Kolbus F, Wei\u00dfbrodt H et al (1995) Manifestations of Chlamydia inducted arthritis in patients with silent versus symptomatic urogenital chlamydial infection. Clin Exp Rheumatol 13:453\u2013458","journal-title":"Clin Exp Rheumatol"},{"key":"1281_CR4","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0889-857X(03)00027-9","volume":"29","author":"Kuipers","year":"2003","unstructured":"Kuipers JG, Zeidler H, K\u00f6hler L (2003) How does Chlamydia cause arthritis? Rheum Dis Clin North Am 29:613\u2013629","journal-title":"Rheum Dis Clin North Am"},{"key":"1281_CR5","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0950-3579(98)80039-3","volume":"12","author":"K\u00f6hler","year":"1998","unstructured":"K\u00f6hler L, Zeidler H, Hudson AP (1998) Aetiological agents: their molecular biology and phagocyte-host interaction. Baillieres Clin Rheumatol 12:589\u2013609","journal-title":"Baillieres Clin Rheumatol"},{"key":"1281_CR6","first-page":"734","volume":"25","author":"Gerard","year":"1998","unstructured":"Gerard HC, Branigan PJ, Schumacher HR Jr, Hudson AP (1998) Synovial chlamydia trachomatis inpatients with reactive arthritis\/Reiter\u2019s syndrome are viable but show aberrant gene expression. J Rheumatol 25(4):734\u2013742","journal-title":"J Rheumatol"},{"key":"1281_CR7","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1002\/1529-0131(200111)44:11<2679::AID-ART447>3.0.CO;2-C","volume":"44","author":"Schnarr","year":"2001","unstructured":"Schnarr S, Putschky N, Jendro MC et al (2001) Chlamydia and Borrelia DNA in synovial fluid of patients with early undifferentiated oligoarthritis; results of o prospective study. Arthritis Rheum 44:2679\u20132685","journal-title":"Arthritis Rheum"},{"key":"1281_CR8","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/ard.58.11.661","volume":"58","author":"Kuipers","year":"1999","unstructured":"Kuipers JG, Kohler L, Zeidler H (1999) Reactive or infectious arthritis. Ann Rheum Dis 58:661\u2013664","journal-title":"Ann Rheum Dis"},{"key":"1281_CR9","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/01.bor.0000126150.04251.f9","volume":"16","author":"Zeidler","year":"2004","unstructured":"Zeidler H, Kuipers J, K\u00f6hler L (2004) Chlamydia-induced arthritis. Curr Opin Rheumatol 16:380\u2013392","journal-title":"Curr Opin Rheumatol"},{"key":"1281_CR10","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/00002281-199807000-00005","volume":"10","author":"Wollenhaupt","year":"1998","unstructured":"Wollenhaupt H, Zeidler H (1998) Undifferentiated arthritis and reactive arthritis. Curr Opin Rheumatol 10:306\u2013313","journal-title":"Curr Opin Rheumatol"},{"key":"1281_CR11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/art.504","volume":"46","author":"Sieper","year":"2002","unstructured":"Sieper J, Rudwaleit M, Braun J, Hejde D van der (2002) Diagnosis reactive arthritis: role of clinical setting in the value of serologic and microbilogic assays. Arthritis Rheum 46(2):319\u2013327","journal-title":"Arthritis Rheum"},{"key":"1281_CR12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-2008-1043505","volume":"25","author":"Kuipers","year":"2000","unstructured":"Kuipers JG, Zeidler H, Wollenhaupt J, K\u00f6hler L (2000) Diagnostik der reaktiven Arthritiden. Akt Rheumat 25:22\u201329","journal-title":"Akt Rheumat"},{"key":"1281_CR13","first-page":"35","volume":"66","author":"Kuipers","year":"1999","unstructured":"Kuipers JG, Wollenhaupt J, Klos A, Zeidler H (1999) Critical appraisal of molecular biological techniques for detecting bacteria in synovial specimens. Rev Rhum Engl Ed 66(Suppl):35\u201385","journal-title":"Rev Rhum Engl Ed"},{"key":"1281_CR14","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1136\/ard.2005.045484","volume":"65","author":"Putschky","year":"2006","unstructured":"Putschky N, Pott HG, Kuiperes JG et al (2006) Comparing 10-day and 4-month doxycycline courses for treatment of Chlamydia trachomatis-reactive arthritis: a prospective, double-blind trial. Ann Rheum Dis 65(11):1521\u20131524","journal-title":"Ann Rheum Dis"},{"key":"1281_CR15","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/1529-0131(199907)42:7<1386::AID-ANR12>3.0.CO;2-E","volume":"42","author":"Sieper","year":"1999","unstructured":"Sieper J, Fendler C, Laitko S et al (1999) No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated Oligoarthritis: a three-month multicenter, double-blind, randomized, placebo-controlled study. Arthritis Rheum 42:1386\u20131396","journal-title":"Arthritis Rheum"},{"key":"1281_CR16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/art.1780340103","volume":"34","author":"Lauhio","year":"1991","unstructured":"Lauhio A, Leirisalo-Repo M, Lahdevirta J et al (1991) Double-blind placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum 34:6\u201314","journal-title":"Arthritis Rheum"},{"key":"1281_CR17","first-page":"1973","volume":"31","author":"Carter","year":"2004","unstructured":"Carter JD, Valeriano J, Vasey FB (2004) Doxycyclin versus doxycycline and rifampin in undifferentiated spondyloarthropathy with special reference to Chlamydia-induced arthritis. A prospective, randomized 9-month comparison. J Rheumatol 31:1973\u20131980","journal-title":"J Rheumatol"},{"key":"1281_CR18","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/ard.59.7.565","volume":"69","author":"Yli-Kerttula","year":"2000","unstructured":"Yli-Kerttula T, Luukainen R, Yli-Kertula U et al (2000) Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis. Ann Rheum Dis 69:565\u2013570","journal-title":"Ann Rheum Dis"},{"key":"1281_CR19","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/art.27394","volume":"62","author":"Carter","year":"2010","unstructured":"Carter JD, Espinzona LR, Inman RD et al (2010) Combination antibiotics as a treatment for chronic Chlamydia-inducted reactive arthritis. Arthritis Rheum 62:1298\u20131307","journal-title":"Arthritis Rheum"},{"key":"1281_CR20","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1128\/AAC.45.11.3001-3008.2001","volume":"45","author":"Dreses-Werringloer","year":"2001","unstructured":"Dreses-Werringloer U, Padubrin I, Zeidler H, Kohler L (2001) Effects of azithromycin and refampin on Chlamydia trachomatis infection in vitro. Antimicrob Agents Chemother 45(11):3001\u20133008","journal-title":"Antimicrob Agents Chemother"},{"key":"1281_CR21","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/art.1780380507","volume":"38","author":"Dougados","year":"1995","unstructured":"Dougados M, Linden S vam der, Leirisalo-Repo M et al (1995) Sulfasalazine in the treatment of spondyloarthropathy. A randomized, multicenter, double-blind, placebo-controlled study. Arthritis Rheum 38(5):618\u2013627","journal-title":"Arthritis Rheum"},{"key":"1281_CR22","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00296-009-0965-9","volume":"30","author":"Schafranski","year":"2010","unstructured":"Schafranski MD (2010) Infliximab for reactive arthritis secondary to Chlamydia trachomatis infection. Rheumatol Int 30:679\u2013680","journal-title":"Rheumatol Int"},{"key":"1281_CR23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/RHU.0b013e3181d06f70","volume":"16","author":"Wechalekar","year":"2010","unstructured":"Wechalekar MD, Rischmueller M, Whittle S et al (2010) Prolonged remission of chronic reactive arthritis treated with three infusions of infliximab. J Clin Rheumatol 16:79\u201380","journal-title":"J Clin Rheumatol"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-013-1281-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-013-1281-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-013-1281-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T16:36:17Z","timestamp":1559061377000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-013-1281-z"}},"subtitle":["\u00c4tiopathogenese \u2013 klinische Manifestationen \u2013 Therapie"],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1281"],"URL":"https:\/\/doi.org\/10.1007\/s00393-013-1281-z","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}